Bright Path Labs  chosen as a collaborator in a first-ever National Science Foundation Engines Award

Bright Path is proud to have been chosen to collaborate with the The Puerto Rico  Science, Technology, & Research Trust in a $1M NSF Innovation Engines Development Award

Feb 18, 2020

RICHMOND, VA

Bright Path Pharmaceuticals, LLC (privately held) today announced that the Medicines for All Institute, a joint venture between Virginia Commonwealth University and the Gates Foundation, has selected BPP as its’ first commercial innovation manufacturing partner.

Dr. Frank Gupton, Executive Director of Medicine for All Institute, “We are very excited about the company’s innovations and are anxious to work together to provide better access to medicines at a more affordable price point.”

Anthony Quinones, Chief Impact Officer of Bright Path Pharmaceuticals, said, “The company is thrilled to join Dr. Gupton and Med4All as strategic partners.” Mr. Allen stated, “As the former North American Head of Chemical Engineering and Manufacturing for Boehringer Ingelheim, Dr. Gupton adds a lot of creditability to our manufacturing initiatives.”

See full article here.